Amid the COVID-19 crisis, the global market for NewBorn Screening estimated at US$793.9 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of 9.6% over the analysis period 2020-2027. Tandem Mass Spectrometry, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$155.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Electrophoresis segment is readjusted to a revised 7.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $214.5 Million, While China is Forecast to Grow at 12.9% CAGR
The NewBorn Screening market in the U.S. is estimated at US$214.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$322.7 Million by the year 2027 trailing a CAGR of 13% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 8.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.
Enzymes & Immunoassays Segment to Record 10.9% CAGR
In the global Enzymes & Immunoassays segment, USA, Canada, Japan, China and Europe will drive the 10.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$209.7 Million in the year 2020 will reach a projected size of US$417.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$215.7 Million by the year 2027, while Latin America will expand at a 11.8% CAGR through the analysis period. We bring years of research experience to this 6th edition of our report. The 385-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others:
- AB Sciex LLC
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- GE Healthcare
- Masimo Corporation
- Medtronic PLC
- Natus Medical, Inc.
- PerkinElmer, Inc.
- Trivitron Healthcare
- Waters Corporation
The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
NewBorn Screening Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
Market Facts & Figures
US NewBorn Screening Market Share (in %) by Company: 2019 & 2025
Market Facts & Figures
European NewBorn Screening Market: Competitor Market Share Scenario (in %) for 2019 & 2025
REST OF EUROPE
REST OF ASIA-PACIFIC
REST OF LATIN AMERICA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
Total Companies Profiled: 46